Metabolic

Featured Article

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

In a meta-analysis of cross-sex hormone therapy use in transgender individuals, researchers found that transgender women may have a greater risk for CVD mortality vs cisgender women in the general population.

Latest Features

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

Cardiovascular Risk Factors in Cross-Sex Hormone Therapy: Expert Opinion

In a meta-analysis of cross-sex hormone therapy use in transgender individuals, researchers found that transgender women may have a greater risk for CVD mortality vs cisgender women in the general population.

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

Lowering LDL Cholesterol HIV: Pitavastatin vs Pravastatin

Pitavastatin had greater low-density lipoprotein-lowering effects than pravastatin.

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

Fasting vs Nonfasting Lipid Values and Cardiovascular Risk: Q&A With Advisory Board Member, Eliot Brinton, MD

Eliot Brinton, MD, FAHA, FNLA, president and director of the Utah Lipid Center, discusses the benefits of fasting lipid profiles in predicting cardiovascular risk.

New Recommendation for Glucose-Lowering Drug Clinical Trials

New Recommendation for Glucose-Lowering Drug Clinical Trials

The International Hypoglycaemia Study Group now recommends that glucose levels lower than 3.0 mmol/L (54 mg/dL) be documented in clinical trials of glucose-lowering drugs.

Understanding Obesity's Role in Atrial Fibrillation

Understanding Obesity's Role in Atrial Fibrillation

The comorbid conditions of obesity and atrial fibrillation require better prevention and treatment strategies.

Preventing Heart Failure One Risk Factor at a Time

Preventing Heart Failure One Risk Factor at a Time

Avoiding 3 major risk factors for heart failure—hypertension, diabetes, and obesity—may reduce the likelihood of heart failure development.

Physical Activity for Diabetes: ADA Updated Guidelines

Physical Activity for Diabetes: ADA Updated Guidelines

Physical activity guidelines were updated for patients with type 2 diabetes, type 1 diabetes, and prediabetes.

Hope for Heart Failure in Thyroid Hormone Therapy

Hope for Heart Failure in Thyroid Hormone Therapy

Subclinicial hypothyroidism has been associated with an increased risk for coronary heart disease events and mortality.

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

PCSK9 Inhibitor Alirocumab Associated With 75% Reduction in Apheresis

Among patients with heterozygous familial hypercholesterolemia, alirocumab was associated with a 75% reduction in lipoprotein apheresis compared with placebo.

Reducing the Progression of Coronary Heart Disease With Estradiol

Reducing the Progression of Coronary Heart Disease With Estradiol

In light of ELITE trial results, estradiol hormone therapy may have a role in coronary heart disease treatment.

Latest News

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

Cardiovascular Disease Risk and Dietary Fat Intake: Update and Expert Roundtable

The American Heart Association has shifted its dietary recommendations from replacing total fat with carbohydrates to replacing saturated and trans fats with unsaturated fat.

Insulin Initiation Associated With Weight Gain, Acitvity Decreases in T2D

Insulin Initiation Associated With Weight Gain, Acitvity Decreases in T2D

Initiation of insulin therapy in patients with type 2 diabetes was associated to inactivity and weight gain.

Multiple Cardiometabolic Comorbidities Prevalent in Psoriasis

Multiple Cardiometabolic Comorbidities Prevalent in Psoriasis

Patients with psoriasis have high rates of cardiometabolic comorbidities.

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

USPSTF Updated Guidelines on Behavioral Counseling for CVD Prevention, Plus Expert Interview

An overview of new USPSTF recommendations for behavioral lifestyle counseling for the prevention of cardiovascular disease plus an expert interview.

Diabetes Increases Hospital Readmissions Rates

Diabetes Increases Hospital Readmissions Rates

Patients with diabetes had a higher rate of readmission to hospitals compared with patients without diabetes.

Two-Hour Postload Glucose Predicts CV Events Better Than Fasting Glucose, HbA1C

Two-Hour Postload Glucose Predicts CV Events Better Than Fasting Glucose, HbA1C

Two-hour postload glucose (2h-PG) may be a better predictor of cardiovascular events in patients with coronary artery disease.

FDA Tentatively Approves Follow-On Biologic Basal Insulin Glargine

FDA Tentatively Approves Follow-On Biologic Basal Insulin Glargine

Tentative FDA approval has been granted to Merck's follow-on biologic basal insulin injection, Lusduna Nexvue.

Chronic Inflammatory Disorders Increase Cardiometabolic and Mortality Risks

Chronic Inflammatory Disorders Increase Cardiometabolic and Mortality Risks

The degree of risk for cardiometabolic events and all-cause mortality increased with nonsteroidal anti-inflammatory drugs and corticosteroid drugs.

CVD Risk in Type 1 Diabetes Improved With Metformin

CVD Risk in Type 1 Diabetes Improved With Metformin

Metformin therapy in type 1 diabetes may improved cardiovascular disease risk management.

FDA to Review Insulin Degludec for Cardiovascular Safety

FDA to Review Insulin Degludec for Cardiovascular Safety

Novo Nordisk submitted an application to the FDA with data on the cardiovascular safety of an insulin degludec.

Sign Up for Free e-Newsletters